EVH Stock Analysis: Buy, Sell, or Hold?
EVH - Evolent Health, Inc Class A Common Stock
$4.72
-0.02 (-0.42%)
âŧ
5d:
+7.03%
30d:
+11.85%
90d:
+19.49%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When EVH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: EVH is fairly priced but lacks strong directional signals. At 4.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: EVH is fairly priced but lacks strong directional signals. At 4.9% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.99
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.96
4.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EVH is currently trading at $4.72, which is considered fair relative to its 30-day fair value range of $3.45 to $5.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.5). At these levels, the market is pricing in 4.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EVH is in a uptrend. The price is approaching resistance at $4.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EVH scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.77 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EVH is in a uptrend. The price is approaching resistance at $4.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EVH scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.77 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.45 -
$5.19
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
51.0%
Protect Your Profits
Holding EVH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.2% below Wall St target ($5.77)
- NEUTRAL: Market pricing in 4.9% annual earnings growth - fairly valued
- WARNING: Composite score 34/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.45 -
$5.19
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.94
Resistance Level
$4.79
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.07
Wall Street Target
$5.77
(+22.2%)
Revenue Growth (YoY)
46.9%
Profit Margin
-24.1%
Valuation Premium vs History
+4.9% premium
PE vs Historical
12.1 vs 10.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.9%
(market-implied from PE analysis)
1-Year Target
$4.95
(+5%)
2-Year Target
$5.19
(+10%)
3-Year Target
$5.45
(+15%)
3-Yr Target (if PE normalizes)
(PE: 12â11)
PE COMPRESSION
$4.74
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 95.8%)
$26.46
(+461%)
Base:
(SPY PE: 12.1, Growth: 95.8%)
$15.93
(+238%)
Bear:
(PE: 10.3, Growth: 95.8%)
$13.54
(+187%)
Share & Embed Analysis
Last updated: August 24, 2026 11:55 PM ET
Data refreshes hourly during market hours. Next update: 12:55 AM
Data refreshes hourly during market hours. Next update: 12:55 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$254 | 34 SELL |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 38 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 42 HOLD |
Advanced EVH Option Strategies
Professional options setups generated by AI based on today's EVH price and gamma walls.
